Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-072001

President and CEO sold 13,515 shares at $14.47 ($195,562)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
AHMED NADIM President and CEO 2026-02-24 Sale −13,515 $14.47 $195,562 390,803 D
Open-market sales · 13,515 sh · avg $14.47 · $195,562
Loading xslF345X05/ownership.xml…